| Predicate |
Object |
| contentType |
Journal Article|Review |
| endingPage |
460 |
| issn |
0040-5957 |
| issueIdentifier |
5 |
| pageRange |
441-460 |
| publicationName |
Therapies |
| startingPage |
441 |
| bibliographicCitation |
Millan MJ. Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies. Therapie. 2005 Sep;60(5):441–60. doi: 10.2515/therapie:2005065. PMID: 16433010. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e479c94aa8b1d30f9105c28e5e158b07 |
| date |
200509 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/16433010
https://doi.org/10.2515/therapie:2005065 |
| isPartOf |
https://portal.issn.org/resource/ISSN/0040-5957
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/7723 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Serotonin 5-HT2C Receptors as a Target for the Treatment of Depressive and Anxious States: Focus on Novel Therapeutic Strategies |
| discusses |
http://id.nlm.nih.gov/mesh/M0001384
http://id.nlm.nih.gov/mesh/M0018620
http://id.nlm.nih.gov/mesh/M0027732
http://id.nlm.nih.gov/mesh/M0018621 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D001007Q000188
http://id.nlm.nih.gov/mesh/D018490Q000627
http://id.nlm.nih.gov/mesh/D044348Q000502
http://id.nlm.nih.gov/mesh/D003863Q000188 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D000339
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000928Q000627
http://id.nlm.nih.gov/mesh/D011985Q000502
http://id.nlm.nih.gov/mesh/D003863Q000503
http://id.nlm.nih.gov/mesh/D003863Q000453 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID896
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_45bd8feabe317d8d0ada3199e40ec54f |